Project Details
Short title | (36MTHS) A Phase 1B Trial to Determine the Immunogenicity and Tolerability of Extended Schedule Vaccination with MVA-EBNA1/LMP2 for Patients with EBV+ Nasopharyngeal Carcinoma |
---|---|
Status | Finished |
Effective start/end date | 1/01/12 → 31/08/16 |
Funding
- Cancer Research UK